Almanack Investment Partners, Llc. 9 Meters Biopharma, Inc. Transaction History

Almanack Investment Partners, Llc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.52 - $1.0 $3,692 - $7,100	-7,100 Reduced 24.4%	22,000 $13,000
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.33 $9,987 - $15,627	-11,750 Reduced 28.76%	29,100 $28,000
Q3 2021 Nov 04, 2021	SELL	$1.03 - $1.41 $11,690 - $16,003	-11,350 Reduced 21.74%	40,850 $53,000
Q2 2021 Aug 04, 2021	SELL	$1.04 - $1.5 $260 - $375	-250 Reduced 0.48%	52,200 $57,000
Q1 2021 May 11, 2021	BUY	$0.84 - $2.16 $44,058 - $113,292	52,450 New	52,450 $61,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

Stay updated on Almanack Investment Partners, Llc. with notifications on news.